{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:55:08Z","timestamp":1791251708467,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.pharma.2013.09.001","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T18:15:32Z","timestamp":1381947332000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Actualit\u00e9 du microbiote intestinal"],"prefix":"10.1016","volume":"72","author":[{"given":"P.","family":"Bourlioux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2013.09.001_bib0005","series-title":"Bonnes bact\u00e9ries et bonne sant\u00e9","author":"Corthier","year":"2011"},{"key":"10.1016\/j.pharma.2013.09.001_bib0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrmicro2973","article-title":"The microbiome explored: recent insights and future challenges","volume":"11","author":"Blaser","year":"2013","journal-title":"Nature Rev Microbiol"},{"issue":"6","key":"10.1016\/j.pharma.2013.09.001_bib0015","first-page":"235","article-title":"Major host health effects ascribed to gut microbiome","volume":"6","author":"Holzman","year":"2011","journal-title":"Microbe"},{"key":"10.1016\/j.pharma.2013.09.001_bib0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/icb.2012.80","article-title":"Intestinal epithelial cells as mediators of the commensal\u2013host immune crosstalk","volume":"91","author":"Goto","year":"2013","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0025","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature10434","article-title":"Peripheral education of the immune system by colonic commensal microbiota","volume":"478","author":"Lathrop","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0030","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11551","article-title":"Reciprocal interactions of the intestinal microbiota and immune system","volume":"489","author":"Maynard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0035","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nri3228","article-title":"Epithelial antimicrobial defence of the skin and intestine","volume":"12","author":"Gallo","year":"2012","journal-title":"Nature Rev Immunol"},{"issue":"6","key":"10.1016\/j.pharma.2013.09.001_bib0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrgastro.2012.44","article-title":"Techniques used to characterize the gut microbiota: a guide for the clinician","volume":"9","author":"Fraher","year":"2012","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0045","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0050","doi-asserted-by":"crossref","unstructured":"The human microbiome project consortium. Structure, functions and diversity of the healthy human microbiome. Nature 2012;486:207\u201314.","DOI":"10.1038\/nature11234"},{"key":"10.1016\/j.pharma.2013.09.001_bib0055","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microflora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharma.2013.09.001_bib0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3920\/BM2012.0029","article-title":"Evolution of the gut microbiota and the influence of diet","volume":"4","author":"Rothe","year":"2013","journal-title":"Benef Microbes"},{"key":"10.1016\/j.pharma.2013.09.001_bib0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/476393a","article-title":"Antibiotic overuse: stop the killing of beneficial bacteria","volume":"476","author":"Blaser","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nature11400","article-title":"Antibiotics in early life alter the murine colonic microbiome and adiposity","volume":"488","author":"Cho","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2013.09.001_bib0085","article-title":"Gut microbiota disturbance during antibiotic therapy: a multi-omic approach","author":"P\u00e9rez-Cobas","year":"2012","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4291\/wjgp.v3.i1.27","article-title":"Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology","volume":"3","author":"Yu","year":"2012","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"8","key":"10.1016\/j.pharma.2013.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.2008.165886","article-title":"Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability","volume":"58","author":"Cani","year":"2009","journal-title":"Gut"},{"issue":"43","key":"10.1016\/j.pharma.2013.09.001_bib0100","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2013.09.001_bib0105","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"issue":"44","key":"10.1016\/j.pharma.2013.09.001_bib0110","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"B\u00e4ckhed","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharma.2013.09.001_bib0115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.4065\/83.4.460","article-title":"Gut microbiota and its possible relationship with obesity","volume":"83","author":"DiBaise","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.pharma.2013.09.001_bib0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nrmicro2876","article-title":"The interplay between the intestinal microbiota and the brain","volume":"10","author":"Collins","year":"2012","journal-title":"Nature Rev Microbiol"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nrgastro.2012.227","article-title":"Microbiota: gut microbes might promote intestinal angiogenesis","volume":"10","author":"Franks","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.pharma.2013.09.001_bib0130","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1073\/pnas.1215927110","article-title":"Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation","volume":"110","author":"Pluznick","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2013.09.001_bib0135","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharma.2013.09.001_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nri3430","article-title":"Role of the gut microbiota in immunity and inflammatory disease","volume":"13","author":"Kamada","year":"2013","journal-title":"Nature Rev Immunol"},{"issue":"5975","key":"10.1016\/j.pharma.2013.09.001_bib0145","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pharma.2013.09.001_bib0150","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nature Med"},{"issue":"3\u20134","key":"10.1016\/j.pharma.2013.09.001_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00281-003-0142-2","article-title":"Effects of intestinal microflora and the environment on the development of asthma and allergy","volume":"25","author":"Bj\u00f6rkst\u00e9n","year":"2004","journal-title":"Springer Semin Immunopathol"},{"issue":"6","key":"10.1016\/j.pharma.2013.09.001_bib0160","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.anaerobe.2011.03.007","article-title":"State of the art; microbiology in health and disease. Intestinal bacterial flora in autism","volume":"17","author":"Finegold","year":"2011","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0165","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00019-12","article-title":"A microbial association with autism","volume":"3","author":"Benach","year":"2012","journal-title":"MBio"},{"issue":"7","key":"10.1016\/j.pharma.2013.09.001_bib0170","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.1010529108","article-title":"Normal gut microbiota modulates brain development and behavior","volume":"108","author":"Diaz Heijtz","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.pharma.2013.09.001_bib0175","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.bbi.2010.10.023","article-title":"Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation","volume":"25","author":"Bailey","year":"2011","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.pharma.2013.09.001_bib0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/embor.2013.27","article-title":"The dynamics of gut-associated microbial communities during inflammation","volume":"14","author":"Winter","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharma.2013.09.001_bib0185","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease: review","volume":"9","author":"Round","year":"2009","journal-title":"Nature Rev Immunol"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0190","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOG.0b013e32835a4b3e","article-title":"Fecal microbiota transplantation: past, present and future","volume":"29","author":"Aroniadis","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0195","unstructured":"Association for Professionals in infection control and epidemiology (APIC) Implementation Guide. Guide to preventing C.\u00a0difficile infections 2013:81\u20135, Washington [http:\/\/apic.org\/Resource_\/EliminationGuideForm\/59397fc6-3f90-43d1-9325-e8be75d86888\/File\/2013CDiffFinal.pdf]."},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MOG.0b013e32835a4b3e","article-title":"Fecal Microbiota Transplantation","volume":"29","author":"Aroniadis","year":"2013","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharma.2013.09.001_bib0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.gie.2013.03.1329","article-title":"An overview of fecal microbiota transplantation: techniques, indications, and outcomes","volume":"78","author":"Brandt","year":"2013","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.pharma.2013.09.001_bib0210","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.pharma.2013.09.001_bib0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1753-4887.2007.tb00272.x","article-title":"Probiotic and prebiotic influence beyond the intestinal tract","volume":"65","author":"Lenoir-Wijnkoop","year":"2007","journal-title":"Nutr Rev"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.pharma.2013.09.001_bib0220","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1073\/pnas.1000079107","article-title":"Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways","volume":"108","author":"van Baarlen","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijmm.2009.08.006","article-title":"Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease","volume":"300","author":"H\u00f6rmannsperger","year":"2010","journal-title":"Int J Med Microbiol"},{"issue":"12","key":"10.1016\/j.pharma.2013.09.001_bib0230","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1371\/journal.pbio.0040413","article-title":"Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host","volume":"4","author":"Sonnenburg","year":"2006","journal-title":"PLoS Biol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0235","unstructured":"Institut Pasteur de Lille. Actes du colloque\u00a0: Sant\u00e9\u00a0\u2013\u00a0Environnement 18\u00a0novembre 2010."},{"key":"10.1016\/j.pharma.2013.09.001_bib0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2013.07.021","article-title":"Gut microbiota limits heavy metals burden caused by chronic oral exposure","author":"Breton","year":"2013","journal-title":"Toxicol Lett"},{"issue":"5","key":"10.1016\/j.pharma.2013.09.001_bib0245","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/AEM.03417-12","article-title":"Protective effects of Lactobacillus plantarum CCFM8610\u00a0against acute cadmium toxicity in mice","volume":"79","author":"Zhai","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0250","unstructured":"Folign\u00e9 B. Communication personnelle au cours de l\u2019audition du 24\/09\/2012."},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijfoodmicro.2006.10.040","article-title":"Rapid removal of lead and cadmium from water by specific lactic acid bacteria","volume":"114","author":"Halttunen","year":"2007","journal-title":"Int J Food Microbiol"},{"issue":"6","key":"10.1016\/j.pharma.2013.09.001_bib0260","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1365-2672.2012.05284.x","article-title":"Characterization of lactic acid bacteria-based probiotics as potential heavy metal sorbents","volume":"112","author":"Bhakta","year":"2012","journal-title":"J Appl Microbiol"},{"issue":"6","key":"10.1016\/j.pharma.2013.09.001_bib0265","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/76516","article-title":"Engineering a mouse metallothionein on the cell surface of Ralstonia eutropha CH34\u00a0for immobilization of heavy metals in soil","volume":"18","author":"Valls","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2008.07.009","article-title":"The gastrointestinal microbiota as a site for the transformation of drugs","volume":"363","author":"Sousa","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2013.09.001_bib0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/019262338801600207","article-title":"Interactions of the gut microflora and the host in toxicology","volume":"16","author":"Rowland","year":"1988","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2012.07.009","article-title":"Developing a metagenomic view of xenobiotic metabolism","volume":"69","author":"Haiser","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.pharma.2013.09.001_bib0285","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C0MB00023J","article-title":"Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro","volume":"7","author":"Aura","year":"2011","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.pharma.2013.09.001_bib0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1235872","article-title":"Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta","volume":"341","author":"Haiser","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.pharma.2013.09.001_bib0295","doi-asserted-by":"crossref","first-page":"A10","DOI":"10.1186\/1471-2105-12-S7-A10","article-title":"PharmacoMicrobiomics or how bugs modulate drugs: an educational initiative to explore the effects of human microbiome on drugs","volume":"12","author":"Aziz","year":"2011","journal-title":"BMC Bioinforma"},{"key":"10.1016\/j.pharma.2013.09.001_bib0300","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nbt.2548","article-title":"Medicines from microbiota","volume":"31","author":"Olle","year":"2013","journal-title":"Nature Biotechnol"},{"key":"10.1016\/j.pharma.2013.09.001_bib0305","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"key":"10.1016\/j.pharma.2013.09.001_bib0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrgastro.2011.244","article-title":"Fecal microbiota transplantation and emerging applications","volume":"9","author":"Borody","year":"2012","journal-title":"Nature Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.pharma.2013.09.001_bib0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharma.2012.08.003","article-title":"La th\u00e9rapie m\u00e9tabolique \u00e0 l\u2019interface entre l\u2019homme et le microbiote intestinal","volume":"71","author":"Blasco-Baque","year":"2013","journal-title":"Ann Pharm Fr"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450913001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450913001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:30:27Z","timestamp":1757719827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450913001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0003450913001107"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2013.09.001","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9 du microbiote intestinal","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2013.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}